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Abstract
Background: Conserved Wnt ligands are critical for signalling during development; however, various factors modulate
their activity. Among these factors are the Secreted Frizzled-Related Proteins (SFRP). We previously isolated the SFRP-
4 gene from an involuting rat mammary gland and later showed that transgenic mice inappropriately expressing SFRP-4
during lactation exhibited a high level of apoptosis with reduced survival of progeny.
Results: In order to address the questions related to the mechanism of Wnt signalling and its inhibition by SFRP-4 which
we report here, we employed partially-purified Wnt-3a in a co-culture model system. Ectopic expression of SFRP-4 was
accomplished by infection with a pBabepuro construct. The co-cultures comprised Line 31E mouse mammary secretory
epithelial cells and Line 30F, undifferentiated, fibroblast-like mouse mammary cells. In vitro differentiation of such co-
cultures can be demonstrated by induction of the β-casein gene in response to lactogenic hormones.
We show here that treatment of cells with partially-purified Wnt-3a initiates Dvl-3, Akt/PKB and GSK-3β
hyperphosphorylation and β-catenin activation. Furthermore, while up-regulating the cyclin D1 and connexin-43 genes and
elevating transepithelial resistance of Line 31E cell monolayers, Wnt-3a treatment abrogates differentiation of co-cultures
in response to the lactogenic hormones prolactin, insulin and glucocorticoid. Cells which express SFRP-4, however, are
largely unaffected by Wnt-3a stimulation. Since a physical association between Wnt-3a and SFRP-4 could be
demonstrated with immunoprecipitation/Western blotting experiments, this interaction, presumably owing to the
Frizzled homology region typical of all SFRPs, explains the refractory response to Wnt-3a which was observed.
Conclusion: This study demonstrates that Wnt-3a treatment activates the Wnt signalling pathway and interferes with
in vitro differentiation of mammary co-cultures to β-casein production in response to lactogenic hormones. Similarly, in
another measure of differentiation, following Wnt-3a treatment mammary epithelial cells could be shown to up-regulate
the cyclin D1 and connexin-43 genes while phenotypically they show increased transepithelial resistance across the cell
monolayer. All these behavioural changes can be blocked in mammary epithelial cells expressing SFRP-4. Thus, our data
illustrate in an in vitro model a mechanism by which SFRP-4 can modulate a differentiation response to Wnt-3a.
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Background
The mammary gland, with each oestrus cycle, undergoes a
round of proliferation and partial differentiation followed
by apoptosis of a fraction of the terminally-differentiated
secretory cells [1-3]. Some years ago we developed the
Lines 31E-30F co-culture model for the study of differen-
tiated functions of mammary epithelial cells responding
to the lactogenic hormones insulin, glucocorticoid and
prolactin by inducing transcription and secretion of the
milk protein β-casein [4,5].
Signalling by the Wnt family of secreted glycoprotein lig-
ands is essential both in embryonic [6,7] as well as adult
development, where they are implicated in the mainte-
nance of stem cell pools [8-12], in tissue differentiation
programs [11-13] and in cell survival [13,14]. It is, there-
fore, unsurprising that the pathogenesis of a variety of dis-
eases, including cancer [11,12,15-17], frequently reflects
disturbances in Wnt signalling.
Although Wnt proteins are secreted, the difficulty in solu-
bilising active Wnt molecules hindered attempts to purify
the Wnts and delayed a thorough biochemical characteri-
sation of this growth factor family. Willert et al. [8]
recently isolated a Wnt-3a-secreting L cell line and devel-
oped a purification protocol allowing Wnt-3a to be
obtained from cell culture supernatants in a biologically
active and relatively pure form. The insoluble nature of
Wnts was explained by the observation that these proteins
are palmitoylated and, thus, more hydrophobic than was
initially predicted from the primary amino acid sequence
[8].
Genetic and biochemical data have demonstrated that the
seven-pass transmembrane Frizzled proteins (Fz) are the
receptors for the Wnts [18,19]. The Frizzled family con-
sists of at least 10 mammalian members and is named
after the Drosophila tissue polarity gene, frizzled (fz). All
members of the Fz family expose an N-terminal extracel-
lular sequence designated the Cysteine-Rich Domain
(CRD), consisting of 120 amino acids including 10 con-
served cysteines, which is able to bind Wnt ligands with
nanomolar affinity [20,21]. Wnt binding, however, also
requires the presence of a co-receptor, a single-pass trans-
membrane molecule of the LRP (Low Density Lipoprotein
Receptor-related Protein) family, either LRP-5 or -6 in ver-
tebrates [22-24]. Wnts bind to LRPs and Fz to form a
receptor trimeric complex [23].
Wnt signals are transduced through at least three intracel-
lular signalling pathways which cross-regulate one
another as well as interacting with other signalling net-
works [25-27]. These are: the Wnt/Ca2+ pathway, the pla-
nar cell polarity pathway (PCP) and the so-called
canonical Wnt/β-catenin pathway. The Wnt/Ca2+ pathway
involves the activation of phospholipase C (PLC) and
leads to elevated Ca2+ levels and the activation of protein
kinase C [28,29]. The PCP pathway acts through small
GTPases such as RhoA and Rac and activated c-Jun amino-
terminal kinase (JNK) [30]. For the canonical Wnt path-
way,  β-catenin ultimately participates in a co-activator
complex in the nucleus with transcription factors of the
TCF/LEF family and several other proteins which regulates
target gene transcription [27,31]. Interestingly, all three
signalling pathways apparently utilize Dishevelled (Dsh
in Drosophila and Dvl in mammals) as a signalling inter-
mediate [26].
In addition to the requirement for an LRP-5/6 co-receptor,
Wnt signalling is modulated extracellularly by diverse
secreted proteins, including members of the Dickkopf
(Dkk) and Secreted Frizzled-related Protein (SFRP or
FrzB) families. Dkk proteins, whose expression is regu-
lated by certain Wnts, do not themselves bind Wnts, but
instead interact with the extracellular domain of the LRPs,
thereby denying activation by Wnts [32,33]. On the other
hand, SFRPs can bind to Wnts by virtue of their CRD,
which is strikingly homologous to that of the Fz receptors,
but lacks any transmembrane domain [25,34-38]. Hence,
as competitors for Wnts, SFRPs can interfere with Wnt-Fz
signalling, but they can also interact directly with the Fz
receptors themselves [39]. Hence, a second way in which
SFRPs might antagonise Wnt signalling is through the for-
mation of a non-functional complex with Frizzled recep-
tors; however, it has not been ruled out that depending on
expression levels or cellular context, SFRPs could promote
Wnt signalling either by protecting Wnts from degrada-
tion or by facilitating Wnt secretion/transport [40].
SFRP-4 was first isolated in our laboratory [36,41] from a
rat ovarian cDNA library (Accession number EMBL:
AF012891) [36]. We subsequently prepared transgenic
mouse lines inappropriately expressing rat SFRP-4 in the
mammary gland during pregnancy and lactation [42].
With these lines, we showed that SFRP-4 expression was
associated with apoptosis in mammary secretory epithe-
lial cells, partly compensated by concomitant increased
cell proliferation, but still resulting in lactational insuffi-
ciency [42].
In the present communication, we report the effects of
treatment with partially-purified Wnt-3a on canonical
Wnt signalling and the impact of ectopic SFRP-4 expres-
sion on signalling intermediates such as β-catenin and
Dishevelled (Dvl) and on downstream Wnt "target gene"
expression. Building on these results, we then investigated
the phenotypes produced by Wnt-3a with and without
ectopic SFRP-4 expression in epithelial cell polarisation
and with the differentiated response in the Line 31E+30FJournal of Molecular Signaling 2008, 3:10 http://www.jmolecularsignaling.com/content/3/1/10
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mouse mammary co-culture model following lactogenic
hormone treatment [4,5].
Results
Because SFRP-4 is strongly upregulated during involution
of the mouse mammary gland and is otherwise virtually
absent from this tissue, we wanted to develop a simplified
mammary model allowing the study of its effects on Wnt
signalling in vitro. In order to be able to study the effects
of ectopically-expressed SFRP-4, we used partially-puri-
fied Wnt-3a prepared by a convenient protocol based on
that described by Willert et al. [8]. To study the phenotype
following Wnt-3a treatment and the impact of SFRP-4 on
this phenotype, we employed the Lines 31E (epithelial)
+30F (fibroblast-like) co-culture model previously devel-
oped in our laboratory [4,5]. Co-cultures respond to lac-
togenic hormone treatment by synthesis and secretion
into the medium of β-casein.
To define the response of these cells to purified Wnt-3a,
we monitored several steps in Wnt signalling pathways:
two parameters used for the Wnt-3a mediated signalling
were hyperphosphorylation of Dishevelled [43,44] and
levels of free cytosolic, or "active" β-catenin [45]. Other
downstream cytoplasmic signalling intermediates, GSK3β
and Akt/PKB [42,46,47] were also evaluated using phos-
pho-specific antibodies on immunoblots. Finally, the
measure of full pathway activation was the expression of
two known Wnt target genes, cyclin D1 [48] and connexin-
43 [49].
Phosphorylation of Dvl
Previous studies have shown that Dvl undergoes hyper-
phosphorylation in response to Wnt signals that stabilise
β-catenin (44; T. Constantinou, unpublished). Among the
Dvl family, Dvl-3 has recently been shown to undergo the
greatest proportional transition from the cytoplasmic to
the plasma membrane compartment after Wnt-3a stimu-
lation [50]. This presumably correlates with phosphoryla-
tion status. Thus, we analysed the effect of Wnt-3a
stimulation on the phosphorylation status of Dvl-3 in our
cells, using a polyclonal antibody specific for Dvl-3 which
was prepared in our laboratory as described in Materials
and Methods. As shown in Fig. 1, Dvl-3 could be detected
with immunoblots as a double band with a molecular
mass of approximately 90 kDa. This double band consists
of hypophosphorylated (lower band) and hyperphospho-
rylated (upper band) Dvl-3. In 30F cells untreated with
Wnt-3a, the lower band is more intense while the upper
band is faint and diffuse. Wnt-3a stimulation results in an
intense, distinct upper band and a fainter lower band.
These differences are also observed in Lines 31E + 30F
(4:1) co-cultures (Fig. 1).
Accumulation of free β-catenin in the cytoplasm
Stabilisation and accumulation of β-catenin in the cyto-
plasm is a hallmark of canonical Wnt signalling and thus
we used β-catenin accumulation in the cytoplasm as a
prime indicator for pathway activation. The pool of β-cat-
enin associated with membrane E-cadherin is much larger
than the relatively small pool of free β-catenin in the cyto-
plasm. Even following stimulation with a Wnt ligand with
concomitant increase in the cytosolic β-catenin, if one
examines a total cell lysate, cytosolic β-catenin is masked
by this large amount of β-catenin present at the mem-
brane. Hence, we analyzed the fraction of free, cytosolic β-
catenin in two ways, i) with cytosolic lysates obtained
after Dounce homogenization of cells swollen in hypot-
onic buffer, and, ii) with lysates obtained by Triton X-100-
containing buffers. Detection of the relative amounts was
with immunoblots, using a "pan" β-catenin-specific anti-
body for the cytosolic lysates (Figs. 2, 4a, 8a), while for
Triton X-100 cell lysates (Fig. 5) detection was with a
monoclonal antibody developed by van der Noort et al.
[45] to detect "active" β-catenin lacking the N-terminal
phosphorylation responsible to its association with the
axin/APC/glycogen synthetase kinase-3β destruction
complex. Both procedures demonstrated the same effects
following Wnt-3a treatment.
For the characterisation of the time-dependent response
to purified Wnt-3a on β-catenin turn-over, mammary cell
lines were treated with 5 μl of the partially-purified Wnt-
3a for several time points (Fig. 2) and analysed using
cytosolic lysates. 30F cells were treated for 1, 2, 4 and 6
hours with Wnt-3a and compared to the control untreated
cells, showing an increase in free, cytosolic β-catenin that
is sustained up to the 6 hour treatment (Fig. 2a). The co-
Dvl-3 as a marker of Wnt pathway activation Figure 1
Dvl-3 as a marker of Wnt pathway activation. Line 30F 
(left panel) or co-cultures of Lines 31E + 30F (right panel) 
stimulated with ectopic Wnt-3a respond with hyperphos-
phorylation of Dvl-3. Following treatment with Wnt-3a for 
the indicated times, cells were lysed with Triton X-100 Lysis 
Buffer and cell extracts were subjected to Western blot anal-
ysis. Hyperphosphorylation of Dvl-3 is evident by a consist-
ent relative increase in the intensity of the upper band of the 
doublet. Alkaline phosphatase treatment caused the loss of 
the upper band (data not shown).
Dvl3
Time (h)
Control +             +
Wnt-3a +            +
2 4
30F cells 31E + 30F
1 46
+            +          +
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cultures of Lines 31E + 30F cells (in proportion 4:1) were
analysed for 2 and 4 hours. Fig. 2b shows that co-cultured
cells responded similarly to the treatment, while the C57
normal Mammary Gland cell line (C57MG) exhibited a
higher differential response in β-catenin accumulation
owing to lower basal levels of cytosolic β-catenin. When
C57MG cells were treated for half an hour, 1 and 2 hours,
cytosolic β-catenin increased in a time dependent manner
(Fig. 2b).
Phosphorylation of Akt and GSK3β
Stimulation of Line 30F or co-cultured 31E + 30F cells
with Wnt-3a for 2 and 4 hours resulted in the phosphor-
ylation of Akt at both Ser473 and (weakly) Thr308 in Tri-
ton X-100 lysates (Fig. 3a, panels 1 and 2). Accordingly,
Akt activity, measured by its ability to phosphorylate
GSK3β at Ser9 with attendant inactivation, was higher in
Wnt-3a-treated than in the control cells (Fig. 3a, panel 4
and Fig. 3b, panel 3). These results show that phosphor-
ylation of both Akt and GSK3β are responses to Wnt-3a
stimulation. The same lysates from the co-culture experi-
ment had been analysed for Dvl-3 hyperphosphorylation
following Wnt-3a treatment (data shown in Fig. 1). Akt
did not interact with Dvl-3 directly as confirmed by co-
immunoprecipitation assays (data not shown). These
results, however, are consistent with the existence of the
postulated cross-talk between Wnt and Akt signalling
[42,46].
Effect of a Wnt Inhibitor, Dickkopf
Modulation of a Wnt-transmitted signal can be controlled
by various inhibitors acting extracellularly, in the cyto-
plasm, or in the nucleus. We were interested in secreted
extracellular inhibitors of Wnt signalling and, more spe-
cifically, in SFRP-4. We wanted to establish whether SFRP-
4 produces a phenotype in mammary cells and whether its
function is through binding to the Wnt-3a ligand, or
through some other mechanism. Dkk-1, a well-character-
ized inhibitor of the Wnt pathway acting in a ligand-inde-
pendent manner was investigated as a control.
Dkk-1 is a secreted antagonist of Wnt/β-catenin signalling
that acts by direct binding to the Wnt co-receptor LRP5/6
and with Kremen in a ternary complex triggering internal-
isation and clearance of LRP5/6 from the cell surface
[32,33]. Thus, Dkk-1 is appropriate for our purpose when
studying Wnt pathway inhibition as it does not depend on
the presence of a particular Wnt ligand for its mode of
action, but instead makes the co-receptor unavailable. To
test this, because of their highly efficient transfection, L
cells were transiently transfected with either Dkk-1 or an
empty (Mock) vector and were then treated with purified
Wnt-3a for 2 and 4 hours. The effect of Dkk-1 was assessed
by analysing the amount of free, cytosolic β-catenin. In
Mock-transfected cells, the amount of β-catenin increases
following Wnt-3a treatment as compared to the control
treated at both time points (Fig. 4, lanes 1, 2, 5 and 6).
Dkk-1 transfected cells, however, fail to induce an increase
in cytosolic β-catenin following stimulation with Wnt-3a
(Fig. 4, lanes 3, 4, 7 and 8). This result is in agreement
with the known mode of action of Dkk-1 [23,32].
Inhibition of Wnt-3a Signalling in Mammary Cells which 
are expressing SFRP-4
The hypothesis that SFRPs compete with Fz receptors for
Wnt ligands has been widely discussed and an inhibitory
activity has been established for SFRP-1 and -2 against
Wnt-3a [51]. Fig. 5 illustrates the response to Wnt-3a
treatment of co-cultured cells where Line 31E cells had
been infected with either pBabepuro vector or pBabepuro
SFRP-4 followed by puromycin selection. In Fig. 5, immu-
noblots are presented in which Triton X-100 lysates were
analysed using a monoclonal antibody specifically reac-
tive with "active", cytosolic β-catenin [45]. Elevated
"active" β-catenin levels, hyperphosphorylation of Dvl-3
and increased levels of phospho (Ser 473) Akt were appar-
ent where the "empty" retroviral vector was employed.
Wnt-3a stimulation of cells infected with pBabepuro SFRP-
Accumulation of β-catenin in the cytosol upon stimulation  with Wnt-3a Figure 2
Accumulation of β-catenin in the cytosol upon stimu-
lation with Wnt-3a. Line 30F cells (a), and co-cultures of 
Lines 31E + 30F or C57MG cells (b) were stimulated with 
purified Wnt-3a or mock-purified conditioned medium 
(Control) for the indicated times. Free cytoplasmic β-catenin 
was obtained by hypotonic lysis using Dounce homogeniza-
tion followed by immunoblot analysis with a broadly reactive 
polyclonal, anti-β-catenin antibody. Increased "free" cytosolic 
β-catenin is evident even after half an hour of Wnt-3a treat-
ment of C57MG cells (b), and is sustained for up to the 6 
hour time point examined with 30F cells (a). Immunodetec-
tion of β-actin served as a loading control.
E-catenin
Control Wnt-3a
Time (h) 1246 1246
1/2 1 2 1/2 1 2 24
+            +  Control +     +      + 
+            +  Wnt-3a +     +     +
Time (h)
C57MG 31E + 30F
a
b
E-actin
E-actin
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4, however, failed to cause elevated levels of "active",
cytosolic β-catenin. Similarly, Line 31E SFRP-4 cells in co-
culture showed no changes in Dvl-3 or phospho (Ser473)-
Akt in response to Wnt-3a. Hence, an inhibitory effect of
SFRP-4 expression on Wnt-3a stimulation was apparent.
Influence of SFRP-4 on Wnt-dependent Gene Expression
The canonical Wnt signalling pathway leads to increased
nuclear localization of β-catenin as a complex with the
TCF/LEF family of transcription factors and to changes in
regulation of gene expression for known "target" genes
[19]. In Fig. 6, Northern blots show responses by 31E+30F
co-cultures to Wnt-3a or epidermal growth factor
(EGF)+insulin stimulation. The cyclin D1 and connexin-43
genes are two recognized targets of stimulation by various
Wnt ligands including Wnt-3a [48,49]. Co-cultures in
which the Line 31E component had been previously
infected with pBabepuroSFRP-4 followed by puromycin
selection failed to exhibit up-regulation of connexin-43
expression in response to Wnt-3a. Interestingly, cyclin D1
expression was still induced by Wnt-3a; however, the
extent of up-regulation was reduced in the presence of the
31E-SFRP4 cells.
Impact of Wnt-3a and SFRP-4 on Differentiated Function 
of Mammary Co-cultures
A functional assay for the effect of Wnt-3a on Line 31E
cells was developed based on its ability to cause increased
transmonolayer electrical resistance on the polarized, nor-
mal mouse epithelial cells [5]. Resistance measurements
were obtained with the Millipore (Bedford, MA., USA)
Millicell-ERS instrument, essentially a milli-volt/ohmme-
ter that provides an alternating voltage source to mini-
mize cell damage. Increased transmonolayer resistance 24
hours following Wnt-3a stimulation (Table 1) is presum-
ably a consequence of upregulation of proteins responsi-
ble for cell: cell adhesion [52]. Table 1 shows that ectopic
SFRP-4 expression in Line 31E cells prevents the increased
transmonolayer resistance exhibited by control Line 31E
cells in response to treatment with purified Wnt-3a.
Wnt signalling induces phosphorylation and activation of Akt/PKB Figure 3
Wnt signalling induces phosphorylation and activation of Akt/PKB. (a) Upon stimulation with 5 μl/ml of purified 
Wnt-3a for 4 hours, Line 30F cells show an elevation of phoshorylated Akt in both Ser473 (panel 1) and Thr308 (panel 2) 
which coincides with phosphorylation of GSK3β at Ser9/21 (panel 4), reflecting its inactivation by Akt. Total Akt was used as a 
loading control by stripping the membrane and reprobing with an anti-Akt antibody (panel 3). β-actin was used as a loading 
control for pGSK-3β (panel 5). (b) Treatment of 31E + 30F co-cultures with purified Wnt-3a for 2 and 4 hours also resulted in 
phosphorylation of Akt at Ser473 (panel 1) and of GSK-3α and -3β at Ser9/21 (panel 3).
Akt
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β-casein expression is a marker for differentiated, func-
tional secretory mammary epithelial cells. This response
can be elicited in vitro with 31E+30F co-cultures (4:1) fol-
lowing treatment with the lactogenic hormones insulin,
glucocorticoid and prolactin. Wnt-3a treatment quantita-
tively inhibits this differentiated response (Fig. 7); how-
ever, co-cultures made with 31E cells stably expressing
SFRP-4 are able to respond functionally to lactogenic hor-
mone treatment, presumably because, as shown above,
they show a diminished signalling response to Wnt-3a.
Physical Association of Wnt-3a with SFRP-4
It is reasonable to assume that SFRP-4 might exert its effect
by competing with Fz for the Wnt ligand. Indeed, a phys-
ical association has been shown in vitro for several SFRPs
with Wnts [38]. We, therefore, investigated the possible
interaction between Wnt-3a and SFRP-4. To perform this
experiment, HEK293 cells were stably transfected with an
SFRP-4 plasmid construct tagged with a triple influenza
hemagglutinin (HA tagged) motif. These cells were then
treated with Wnt-3a for 4 hours. Cytosolic lysates were
collected and analysed for the level of β-catenin using a
Western Blot procedure. The parental HEK293 cells exhib-
ited stimulation after treatment with two different
amounts of purified Wnt-3a as shown by the elevation of
cytosolic β-catenin (Fig. 8a, lanes 2 and 3). In contrast,
HEK293 cells expressing SFRP-4(HA tagged) failed to
accumulate β-catenin in the cytosol upon Wnt-3a treat-
ment (Fig. 8a, lanes 5 and 6). Conditioned medium (CM)
from HEK293 SFRP-4(HA tagged) cells treated with 5 μl/
ml of purified Wnt-3a for 4 hours was saved and used to
investigate whether SFRP-4 and Wnt-3a formed com-
plexes. This was done with an immunoprecipitation/
Western blot experiment. Supernatant medium was incu-
bated with a rabbit anti-HA tag-specific antibody, com-
plexes isolated, electrophoresed and immunoblotted.
Detection was performed, firstly, using a mouse anti-HA
tag antibody. Fig. 8b shows the presence of immunopre-
cipitated SFRP-4(HA tagged) which had been secreted
into the medium (Fig. 8b, first lane). SFRP-4(HA tagged)
SFRP-4 interferes with Wnt-3a signalling in Lines 31E + 30F  co-cultures Figure 5
SFRP-4 interferes with Wnt-3a signalling in Lines 31E 
+ 30F co-cultures. pBabeSFRP-4-infected, puromycin-
selected, 31E cells in co-culture with 30F cells fail to show 
Wnt and Akt signalling activation by Wnt-3a. Treatment with 
Wnt-3a induced a hyperphosphorylation of Dvl-3, an 
increase in Akt phosphorylation (Ser473), and raised the lev-
els of "active" β-catenin in the absence (pBabeV, vector), but 
not in the presence of the SFRP-4 cells.
31E+30F
pBabeV
31E+30F
pBabeSFRP4
Wnt3a --
2.5Pl +
5Pl +              +
active E-catenin
Dvl-3
pAkt ser473
E-actin
Inhibition of Wnt-3a pathway activation by Dkk-1 Figure 4
Inhibition of Wnt-3a pathway activation by Dkk-1. L 
cells were transiently transfected with an empty vector 
(Mock) or with a plasmid encoding Dkk-1 and were either 
control-treated or purified Wnt-3a-treated for 2 and 4 
hours. (a) At both time points cells transfected with the 
Dkk-1 plasmid fail to induce accumulation of cytoplasmic β-
catenin upon Wnt-3a treatment, as detected by Western 
Blot. In contrast, Mock transfected cells show an elevation in 
the level of β-catenin upon Wnt-3a treatment. (b) The 
detection of β-actin served as a loading control. (c) Parallel 
plates were treated as above and lysates were collected for 
extraction of total RNA. Dkk-1 mRNA is shown by Northern 
Blot in the cells transfected with Dkk-1. (d) 18S and 28S 
rRNA bands are loading controls obtained by acridine orange 
staining of the gel used for the Northern Blot prior to blot-
ting.
ȕ-catenin
Mock
2 hrs 4 hrs
Wnt-3a
Control +             +             +            +
+             +            +             +
Dkk-1 Mock Dkk-1
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E-actin
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from a total cell lysate (TCL) made with a parallel plate is
shown in Fig. 8b (middle lane). There is some difference
in the mobility of the two proteins; one explanation could
be further post translational modification (maturation) of
the secreted, free SFRP-4. The same blot was then re-
probed with anti-Wnt-3a antibody revealing that Wnt-3a
apparently does co-precipitate with SFRP-4 secreted into
the CM (Fig. 8b (first lane), but is not observed with the
band from the TCL (middle lane). The last lane (Fig. 8b)
was loaded with a total cell lysate from Wnt-3a-producing
L cells as a control.
Discussion
As with many developmental genes, it was the recognition
that tumours were caused by inappropriate Wnt-1 expres-
sion in many cases of mouse mammary tumour virus dis-
ease which focused attention on the fundamental role of
Wnts in development, control of cell proliferation and dif-
ferentiation [6]. The canonical Wnt pathway exhibits so
many facets because it is itself responsive to a great many
stimulatory and inhibitory signals. Not only are there
multiple Wnt ligands acting on multiple Fz receptors [29]
as modulated by the competitive, inhibitory activities of
the SFRPs [25], but there is the dependence on co-receptor
function from the LRPs, again as influenced by expression
the Dkk proteins [27,32]. In this complex system, it seems
certain that the ultimate developmental message decoded
in different target cell populations can be quite different
according to differentiation status, and perhaps, even the
nutritional conditions in which the recipients find them-
selves. At the very least, other signalling pathways will
contribute nuances to the decoded message [29].
The history of the Wnts in mammals began with mam-
mary tumours; thus, it seemed appropriate to study a
mammary model. Our goal in this study was to examine
the role of Wnt signalling in affecting mammary cell pro-
liferation and differentiated function, and then to ask,
how SFRP-4 would modify the message and change the
resulting cell phenotype. At the same time, it was desirable
to present a Wnt ligand which was biologically active and
partially purified to be relatively free of other factors
which could complicate the analysis. This requirement
was met by taking advantage of the L cell system secreting
soluble, active Wnt-3a, and a simplified purification pro-
tocol [8].
As first step we characterized the mammary cells and co-
culture model with respect to the Wnt-3a response in a
signalling pathway. The co-culture model comprises two
cell lines: Line 31E, a polarized epithelial cell exhibiting a
high transmonolayer resistance, and forming typical
"domes" on plastic substrates [5], and Line 30F, a fibrob-
last-like, undifferentiated cell type, lacking the characteris-
tics of polarization and expressing vimentin. For optimal
lactogenic hormone response, Line 31E cells must be
plated with Line 30F cells, which apparently contribute to
the formation of "organoid-like" structures [4]. Following
dexamethazone, insulin and prolactin treatment, co-cul-
tured cells express β-casein mRNA and secrete β-casein
protein [5].
We monitored the canonical pathway of response to Wnt-
3a treatment by following Dvl-3 hyperphosphorylation
and levels of free, cytosolic β-catenin in Western blots.
Global Dvl-1, -2, and -3 phosphorylation has been impli-
cated as an activating step that allows Dvl to signal down-
Cyclin D1 and connexin-43 mRNA expression in Lines 31E +  30F co-cultures after Wnt-3a stimulation Figure 6
Cyclin D1 and connexin-43 mRNA expression in Lines 
31E + 30F co-cultures after Wnt-3a stimulation. 
Northern blots were employed to show the expression of 
cyclin D1 and connexin-43 polyA+ RNAs after stimulation of 
the cultures for 12 hours with Wnt-3a or insulin + epidermal 
growth factor (EGF). Co-cultures, made with either pBabeV-
ector or pBabeSFRP-4-infected Line 31E cells together with 
Line 30F cells, were maintained in 3% serum-containing 
medium and compared in their responses to Wnt-3a. With 
Line 31E-Vector cells (31E-V) in co-culture, either Wnt-3a 
alone or insulin + EGF (Ins+EGF) treatments elicit stimula-
tion of cyclin D1 (CD1) mRNA expression, whereas connexin-
43 (Cx43) expression responds only to Wnt-3a, and is 
strongly inhibited by EGF+insulin. A response to Wnt-3a was 
not seen; however, when co-cultures were made using Line 
31E cells expressing pBabeSFRP-4 (31E-SFRP4), up-regulation 
of connexin-43 but not cyclin D1 was prevented. However, 
cyclin D1 mRNA up-regulation is reduced compared to the 
co-cultures containing Line 31E-Vector cells. Residual ribos-
omal RNA (loading control) was stained with acridine 
orange.
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stream to β-catenin [27,44]. Experiments shown in Figs. 1
and 2 illustrate these responses to purified Wnt-3a. Dvl-3
hyper-phosphorylation and elevated levels of cytosolic β-
catenin could be detected within 1/2 to 1 hour and was
maintained up to at least 6 hours. Furthermore, as shown
in Fig. 3, Wnt-3a stimulation leads to increased phospho-
rylation of Akt/PKB at Ser473 and slightly at Thr308. A
parallel hyperphosphorylation in Glycogen Synthase
Kinases (GSK-3α and -3β) was also observed, both in Line
30 F cells alone, and in the co-cultures of 31E + 30F. Phos-
phorylation of both Akt and GSK3β are responses to Wnt-
3a stimulation [42,47]. These same lysates from the co-
culture experiment had been analysed for Dvl-3 hyper-
phosphorylation following Wnt-3a treatment (shown in
Fig. 1). This probably explains why other factors, such as
insulin and EGF, that stimulate Akt through the PI3K
pathway, but do not activate Dvl, fail to cause an increase
in cytosolic β-catenin. Akt did not interact with Dvl-3
directly as confirmed by co-immunoprecipitation (data
not shown) and all these results indicate the existence of
postulated cross-talk between Wnt and Akt signalling [46]
although the mechanism involved needs to be confirmed.
We postulate that Dvl interaction with Axin induces a con-
formational change, allowing Axin-bound GSK3β to be
phosphorylated by Akt [42,46]. This phosphorylated
GSK3β cannot modify β-catenin efficiently and this
results in accumulation in the cytosol. Independent of the
exact mechanism involved, the observed phosphorylation
of Akt as a consequence of Wnt stimulation is relevant for
explaining the anti-apoptotic role of Wnts as survival fac-
tors [42-47].
The Wnt-3a-imposed abrogation of differentiated response to lactogenic hormones was mitigated in pBabeSFRP-4-infected  Line 31E cells Figure 7
The Wnt-3a-imposed abrogation of differentiated response to lactogenic hormones was mitigated in pBabeS-
FRP-4-infected Line 31E cells. Using Northern blot methods, the expression of β-casein was investigated after stimulation 
of cultures with Wnt-3a and/or different combinations of growth factors and lactogenic hormones. Lines 31E +30F co-cultures 
containing either pBabeVector or pBabeSFRP-4-infected Line 31E cells were compared. Most notable is that Wnt-3a is capable 
of completely suppressing the differentiation to β-casein expression stimulated by dexamethazone-insulin-prolactin (DIP). 
However, co-cultures containing Line 31E cells infected with SFRP-4 show definite β-casein induction in spite of Wnt-3a treat-
ment. Ribosomal RNA was stained with acridine orange as a loading control.
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Table 1: Electrical resistance across monolayers of cultured Line 31E mammary epithelial cells
Cell Type Treatment Transmonolayer resistance* (Ohms × cm2)
31E-pBabeVector w/o Wnt-3a 290 +/- 22
+ Wnt-3a 620 +/- 36
31E-pBabeSFRP-4 w/o Wnt-3a 250 +/- 18
+ Wnt-3a 310 +/- 27
* Cultures previously selected with puromycin were grown on nitrocellulose filter inserts (2.2 cm diameter) for 48 hrs prior to adding treatment 
with or without Wnt-3a at 5 μl/ml for a further 28 hrs. Values shown are the mean +/- S.E.M. of 5 measurements made on parallel inserts taken 
across the membrane from apical to basal sides with the Millicell ERS instrument.Journal of Molecular Signaling 2008, 3:10 http://www.jmolecularsignaling.com/content/3/1/10
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With the goal of establishing the possible nature of an
inhibitory activity of SFRP-4 on Wnt-3a stimulation, we
used Dickkopf as a control, an inhibitor known to inter-
fere with all Wnt signalling by virtue of competing for the
essential co-receptors, LRP-5 or -6. Fig. 4 illustrates this
inhibition of Wnt-3a stimulation using increased
cytosolic β-catenin as a marker. Using as a measure the
"active" β-catenin levels [45] and Dvl-3 hyperphosphor-
ylation as parameters, Fig. 5 demonstrates that SFRP-4-
infected co-cultured cells are also inhibited in their
responses to Wnt-3a.
The end effect of Wnt-3a stimulation of mammary cells is
a phenotypic change conferring in vitro corresponding
changes in cell proliferation and in cell biological behav-
iour. Monitoring the expression of two known target
genes of Wnt signalling, we could show that both Wnt-3a
and insulin/EGF treatments cause an up-regulation in cyc-
lin D1 mRNA expression (Fig. 6). Connexin-43 expres-
SFRP-4 binds to Wnt-3a, and thereby prevents activation of the β-catenin pathway Figure 8
SFRP-4 binds to Wnt-3a, and thereby prevents activation of the β-catenin pathway. (a) HEK293 and HEK293 
transfected with SFRP-4(HA tagged) were either control-treated or purified Wnt-3a-treated for 4 hours. Cytosolic lysates 
were analysed by Western Blot for the levels of β-catenin. Pathway activation is indicated by the increase in cytosolic β-catenin 
upon Wnt-3a treatment seen only in the parental HEK293 cells whereas in the SFPR-4-expressing cells this effect was abol-
ished. (b) conditioned medium supernatant (CM) prepared from the HEK 293 cells expressing SFRP-4(HA tagged) after treat-
ment with 5 μl Wnt-3a for 4 hours in the above experiment, was immunoprecipitated with an anti-HA-tag antibody, 
electrophoresed, Western blotted and, firstly, detected with an anti-HA-tag antibody. The first lane shows the precipitated 
SFRP-4 containing the HA tag from the CM. The middle lane shows the presence of the same protein in the total cell lysate 
(TCL) of the same cells as a control. The membrane was then re-probed with affinity-purified anti-Wnt-3a antibody, showing 
binding of Wnt-3a to the immunoprecipitated SFRP-4(HA tagged) from the conditioned medium supernatant (first lane), but 
not in the total cell lysate (middle lane). In addition, a sample of TCL from L cells expressing Wnt-3a (Fig. 8b, last lane), which 
had not been subjected to immunoprecipitation, served as a control demonstrating the detection of Wnt-3a protein.
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sion does not respond to Insulin/EGF, but is up-regulated
by Wnt-3a. When co-cultures containing Line 31E cells
infected with pBabeSFRP-4 were employed for the same
experiment, the stimulatory activity of Wnt-3a was
reduced, although the Insulin/EGF effect was unchanged
(Fig. 6).
Most dramatic was the differentiated response of co-cul-
tures in Fig. 7 after treatment with dexamethazone, insu-
lin and prolactin (DIP). β-casein mRNA expression was
completely abrogated by Wnt-3a treatment of co-cultures
containing Line 31 E cells infected with pBabe Vector (Fig.
7). Co-cultures containing pBabe SFRP-4-infected Line
31E cells, however, showed β-casein expression only
slightly reduced by Wnt-3a treatment. The fact that the
results were less clear-cut for cyclin D1 and connexin-43
(Fig. 6) is explainable because the 20% of the cell popula-
tion made up of Line 30F cells is entirely unable to make
β-casein and thus makes no contribution (Fig. 7), whereas
Line 30F cells do respond to Wnt-3a for cyclin D1 and
connexin-43. Thus, SFRP-4 seems unable to function
"para" in these co-cultures.
It has been widely postulated that the effect of SFRP-4 on
Wnt stimulation is a consequence of competition with Fz
for ligand availability [25,38]. Using an immunoprecipi-
tation/Western blotting experiment similar to that of
Wawrzak et al. [38], the results in Fig. 8 show that SFRP-4,
tagged for convenience with an HA marker, physically
associates with Wnt-3a. HEK293 cells were employed for
this experiment, because of the better transfection effi-
ciency and SFRP-4 secretion/release.
Our results present a coherent view of the role of Wnt
stimulation in behavioural changes in mammary epithe-
lial cells, and how SFRPs can modulate such changes.
Multiplied by the variety of Wnt, Fz and SFRP players, it is
possible to see, how even just within this organ, complex
behavioural permutations could be achieved. One feature
of the Wnts, their insolubility and association with extra-
cellular matrix components, provokes speculation that
their action in vivo will be long-lasting in fields surround-
ing the producing cells, presumably in a concentration
gradient. In fact, numerous in vivo studies address the role
of Wnt signalling in different stem cell populations [8-
11], and in various developmental stages of mammary
development [12]. It is an interesting feature of SFRPs,
being as they are, secreted, and responding rapidly to tran-
scriptional regulation [53], that they offer a mechanism
for saturating and neutralizing long-lasting extracellular
matrix-bound Wnt-activity fields. Since from the outset of
work with SFRP-4 [41], its role seemed to be in the induc-
tion of apoptosis in various systems, its future potential in
cancer therapy justifies active research on its function in
different developmental contexts.
A particularly intriguing thought would be to speculate
that SFRP-4 could abrogate a survival mechanism in
breast cancer stem cells, assuming both that such cell
types indeed exist, and that they are "sufficiently" similar
to mammary alveolar progenitors in which β-catenin sig-
nalling is necessary for mammary development and preg-
nancy-induced proliferation [reviewed in Ref. [54]].
Conclusion
This study demonstrates that Wnt-3a treatment interferes
with in vitro differentiation of mammary co-cultures to β-
casein production in response to lactogenic hormones.
Similarly, in another measure of differentiation, following
Wnt-3a treatment mammary epithelial cells could be
shown to up-regulate the cyclin D1 and connexin-43 genes
while phenotypically they show increased transepithelial
resistance across the cell monolayer. All these behavioural
changes can be blocked in mammary epithelial cells
expressing SFRP-4. A physical association between Wnt-3a
and SFRP-4 was demonstrated. Thus, our data illustrate in
an in vitro model a mechanism by which SFRP-4 can mod-
ulate a differentiation response to Wnt-3a.
Methods
Cell Cultures, Plasmid Constructs and Transfections
The mouse mammary epithelial Line 31E and fibroblast-
like 30F were originally established from BALB/c mice in
our laboratory [4] and were used to develop a co-culture
model allowing functional differentiation of mammary
cells to β-casein production in vitro [5]. These cells were
routinely maintained in Eagle's Dulbecco-modified
medium enriched with 10% foetal calf serum (EDM10).
The co-cultures were established with densities of Line
31E to Line 30F in the ratio of 4:1. After culture for 48 hrs
initially in EDM supplemented with EGF (10 ng/ml) and
insulin (5 ug/ml), for lactogenic induction, cells were
changed for 24 hrs to medium with 3% foetal calf serum,
5 ug/ml insulin, 1 ug/ml hydrocortisone and 5 ug/ml
ovine prolactin. HEK 293 and L cells were employed for
some experiments and were also maintained in EDM with
10% foetal calf serum, except that no EGF/insulin supple-
ment was used.
Rat SFRP-4 [36] (Accession no. EMBL: AF 012891) cDNA
was subcloned into the pcDNA6 (Invitrogen, Paisley, UK)
plasmid containing a triple HA tag and into the pBabepuro
[55] retroviral vector. The Phoenix retroviral packaging
cell line was the gift of Dr. Gerry Nolan [56] and was
employed for preparation of infectious pBabepuro SFRP-4.
For infection of 30 F cells, a multiplicity of 0.5 to 1 was
employed, followed after 48 hrs by transfer and selection
with puromycin 2.5 μg/ml for a further 3 days.
The human Dkk1 gene was a generous gift of Dr C. Niehrs
(DKFZ, Heidelberg). L cells were plated at a density of 10Journal of Molecular Signaling 2008, 3:10 http://www.jmolecularsignaling.com/content/3/1/10
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× 105 per 10 cm dish, grown to 50–60% confluence and
were then transfected with 20 μg of plasmid DNA with
FuGENE 6 (Roche) according to the manufacturer's
instructions. At 48 hrs post transfection, stimulation with
purified Wnt-3a was performed and samples were col-
lected for analysis. For stable transfectants, 48 hrs post
transfection, cells were trypsinised and plated at 5 × 105
per 10 cm dish in the presence of Blasticidin (10 μg/ml)
for the pcDNA6-SFRP-4(HA) construct.
Purification of Wnt-3a
The preparation of partially-purified Wnt-3a was per-
formed with a simplified protocol based on that described
by Willert et al. [8]. Briefly, conditioned medium was har-
vested from L Wnt-3a cells (American Type Culture Col-
lection) grown in EDM with 10% FCS at 2 day-intervals,
cleared from cellular debris by centrifugation and stored
at 4°C. 600 ml of such conditioned medium was adjusted
to 1% Triton X-100, filtered through a 0.2-μm Millipore
filter and applied to a Cibacron Blue F3G-A Sepharose 6
Fast Flow (Amersham Biosciences, Little Chalfont, Eng-
land) column (bed volume of 50 ml), which had been
previously equilibrated in binding buffer (150 mM KCl,
20 mM Tris-HCl pH 7.5, 1% Triton X-100). The column
was then washed, first with 150 ml of binding buffer and
then with 50 ml of binding buffer containing CHAPS
instead of Triton X-100. Bound proteins were then eluted
using 80 ml elution buffer (1.5 M KCl, 20 mM Tris-HCl
pH 7.5, 1% CHAPS) and collected in 4 ml fractions. An
aliquot of each fraction was then adjusted to 1 × SDS-
PAGE sample buffer and analysed by SDS-PAGE followed
by immunoblotting and detection with affinity-purified
Wnt-3a-specific antibody. A second aliquot was electro-
phoresed and the bands detected with silver staining. The
Wnt-3a elution peak was very broad according to the
immunoblot. The corresponding band visible with silver
staining was apparent. The same procedure was applied to
conditioned medium from L cells as a control, but the
purified product did not exhibit the Wnt-3a band in the
same elution profile region and no Wnt-like stimulatory
effect was seen in bio-assays. The enrichment obtained for
Wnt-3a was approximately 70-fold. The eluted Wnt-3a
was dialyzed and stored at 4°C. Because it contained
some residual CHAPS which was necessary for solubility,
Wnt-3a was always added to cultures at 2.5 – 5 μl/ml EDM
with 3% foetal calf serum. Control plates received the
mock-purified material (also containing residual CHAPS
after dialysis) from normal L cells.
Treatment of Cells with Wnt-3a and Preparation of 
Lysates
For stimulation experiments involving purified Wnt-3a,
recipient cells (L, C57MG and HEK293 cells) were grown
to confluence for 72 hours in 5 cm cell culture dishes
using 5 ml culture medium. Line 30F cells and the co-cul-
tures of 31E with 30F (4:1 ratio) cells were grown for 48
hours in 5 ml cell culture medium, and for the final 24
hours replaced by culture medium containing 3% foetal
calf serum. 2 ml of medium was collected, supplemented
with purified Wnt-3a (2.5 – 5 μl per ml EDM) or mock-
purified conditioned medium from L cells (control) and
re-applied to the cells after removing the remaining 3 ml
of culture medium.
For determination of cytosolic β-catenin, cytosolic extracts
were prepared after swelling in Hypotonic Lysis Buffer
from confluent cultures on 5 cm plates as follows. Plates
were incubated for 10 min on ice in 0.5 ml of Hypotonic
Lysis Buffer [4 mM Na2HPO4, 20 mM KH2PO4, 3 mM
MgCl2, 10% sucrose, and 1 mM 2-mercaptoethanol, pH
7.5 supplemented with 5 μg each aprotinin and leupeptin,
1 mM each β-glycerophosphate, 6-aminohexanoic acid,
NaF, Na-orthovanadate and phenyl-methyl sulfonyl fluo-
ride (PMSF)]. Following gentle Dounce homogenisation
of swollen cells with 20 strokes, samples were centrifuged
at 20'000 × g for 15 minutes and the resulting supernatant
was designated the cytosolic fraction. After determining
the protein concentration using the Bradford-based Bio-
Rad Protein Assay (Bio-Rad, Hercules, CA, USA), the
cytosolic lysates were diluted to 1× in SDS-PAGE sample
buffer (80 mM Tris (pH 6.8), 2% Na dodecylsulfate
(SDS), 10% glycerol, 2% 2-mercaptoethanol and 0.02%
bromphenol blue) and boiled for 2 minutes.
Total cytoplasmic lysates containing both cytosolic and
cell membrane proteins were obtained using a Triton X-
100 containing Lysis Buffer. Briefly, plates were washed
with Dulbecco's phosphate buffered saline (PBS) without
Ca2+/Mg2+ and incubated at 4°C for 10 min in 1 ml of Tri-
ton X-100 Lysis Buffer (PBS with 1% Triton X-100, 0.25%
Na-deoxycholate, 1 ug/ml each leupeptin and aprotinin, 1
mM each EDTA, EGTA, β-glycerophosphate, 6-aminohex-
anoic acid, NaF, sodium-orthovanadate and PMSF, which
was added to mM before use. Following centrifugation at
20'000 × g for 10 min the supernatants were collected.
After determination of protein concentration using the
Bradford-based Bio-Rad Protein Assay (as above), the
lysates were diluted to 1× SDS-PAGE sample buffer,
boiled and electrophoresed on 7.5% or 10% polyacryla-
mide gels.
Total Cell Lysates (TCL) were collected by lysing cells
directly with 1× SDS-PAGE sample buffer (500 μl for a 5
cm cell culture dish) and boiling for 5 minutes.
Immunoprecipitation Experiments
For immunoprecipitation of SFRP-4, 4 ml of a 72 hour
conditioned medium from HEK293 SFRP-4(HA tagged)
cells was centrifuged at 10'000 × g for 20 minutes. The
cleared supernatant was then collected, mixed 1:1 withJournal of Molecular Signaling 2008, 3:10 http://www.jmolecularsignaling.com/content/3/1/10
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Immunoprecipitation Buffer (Dulbecco PBS without
Ca2+/Mg2+containing 0.25% Triton X-100) and a rabbit
anti-HA tag antibody (Santa Cruz, CA, USA) was added.
This was then incubated at 4°C on a rotator for 5 hours;
thereafter, 25 μl of protein G Sepharose beads (Amersham
Pharmacia Biotech) were added for overnight incubation.
The immunoprecipitated complexes were washed three
times in Immunoprecipitation Buffer. SDS sample buffer
(25 μl) was added, samples were boiled and analysed fol-
lowing electrophoresis by Western blot.
SDS-PAGE
Electrophoretic separation of proteins was performed by
discontinuous (Laemmli) SDS-PAGE using the Mini-
PROTEAN® II electrophoresis cell (Bio-Rad) with an elec-
trophoretic separation length of 7 cm. For immunoblot
analysis of Dvl-3, 7.5% polyacrylamide gels were used;
otherwise 10% polyacrylamide gels were poured using
research-grade 29:1-Acrylamide/Bisacrylamide (Serva,
Heidelberg, Germany). To ensure that equal amounts of
protein were loaded, protein concentration was deter-
mined by using a Bradford-based assay (Bio-Rad Protein
Assay) and/or estimated by Coomassie staining of gels run
in parallel and confirmed by Ponceau S staining of West-
ern blot membranes.
Immunoblot analysis
For Western Blot analysis, proteins were separated by SDS-
PAGE as described above and transferred onto nitrocellu-
lose membranes (Schleicher & Schuell Inc., Dassel, Ger-
many) using a semidry electroblotter (Bio-Rad). After
transfer, the membranes were incubated for 1 hour in
blocking solution (20 mM Tris pH 7.6, 140 mM NaCl,
0.1% Tween-20, 5% w/v non-fat dry milk) and then
washed three times for 5 min with Tris-buffered saline
containing Tween-20 (TBS-T: 20 mM Tris pH 7.6, 140 mM
NaCl, 0.05% Tween-20). Primary antibodies were diluted
1:1000 with TBS-T containing 5% w/v BSA and the mem-
branes were incubated overnight at 4°C with gentle agita-
tion. After three 5 min-washes with TBS-T, the membranes
were incubated for 1 h at room temperature in blocking
buffer containing the secondary antibody diluted 1:1000.
After washing the membranes three more times for 5 min
with TBS-T, the immunoreactive bands were visualised by
chemiluminescence (using SuperSignal®  West Pico
Chemiluminescent Substrate, Pierce, Rockford, IL, USA)
and by exposing the membranes with a CCD camera sys-
tem (Lumi-Imager™, Roche Diagnostics, Rotkreuz, Swit-
zerland). In the case of total Akt, after immunodetection
of Ser473-phosphorylated Akt as described above, the
membrane was stripped by incubation for 30 min at 50°C
with gentle agitation in stripping buffer (62.5 mM Tris-
HCl pH 6.7, 100 mM 2-mercaptoethanol, 2% SDS),
washed twice for 10 min with TBS-T, blocked for 1 hour
with blocking solution and reprobed for total Akt.
Antibodies
Polyclonal antibodies against β-catenin and Dvl-3 were
raised in rabbits in our laboratory. In brief, the antigens
were expressed in E. coli using the inducible pGex expres-
sion system (Amersham Biosciences) and purified by pre-
parative SDS-PAGE. Rabbits were immunised repeatedly
with 500 μg of antigen. For affinity purification, the sera
were incubated with antigen coupled to Affigel-10 (Bio-
Rad) and specific antibodies then eluted using 100 mM
glycine buffer (pH 2.5), neutralized with 0.1 × volume 1
M Tris pH 8.0 after collection of the fraction. Finally, peak
fractions were identified, pooled and dialyzed against PBS
at pH 7.5. The specificity of the antibodies was confirmed
by immunoblotting of in vitro translation products with
the corresponding antibody. The TNT® Coupled Reticulo-
cyte Lysate System (Promega, Madison, USA) was used for
the  in vitro synthesis of β-catenin, and Dvl-3 proteins,
according to the manufacturer's instructions.
A polyclonal rabbit antibody against mouse β-casein was
generously provided by Dr. Ernst Reichmann (Pediatric
Surgery Research, University Hospital, Zurich, Switzer-
land). The remaining antibodies were obtained from
commercial sources: the mouse monoclonal antibody
against cyclin D1 (sc-2004) and the rabbit polyclonal
anti-HA antibody were purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA, USA), the mouse mon-
oclonal  β-actin antibody was from Sigma-Aldrich, the
anti-mouse- and anti-rabbit-IgG-HRP-linked antibodies
were from Amersham Biosciences (Buckinghamshire,
UK), and, finally, the mouse monoclonal anti-HA anti-
body, the anti-phospho-ser473 Akt, the anti-phospho-
thr308 Akt and the anti-Akt antibodies as well as the anti-
phospho-Ser9/21 GSK3 antibodies were from Cell Signal-
ling Technology (Beverly, MA, USA).
Isolation of RNA and Northern blotting
Total RNA was prepared from cells using the guanidin-
ium-thiocyanate extraction method described by Chomc-
zynski and Sacchi [57]. 5 μg of polyA+ RNA was denatured
with glyoxal, electrophoresed on a 1% agarose gel and
blotted to nitrocellulose. Equal loading was controlled by
examination of bands formed by residual ribosomal RNA
following staining with acridine orange, immediately
prior to blotting as previously described [42]. Probes for
hybridization were prepared using the Random Primed
Labelling Kit (Roche) including γ32P-dCTP (800 Ci/mM;
Amersham International, Little Chalfont, England) in the
reaction and hybridization was carried out as previously
described [42].
In Vitro Differentiation Assays
In order to induce functional in vitro differentiation of
Line 31E mouse mammary epithelial cells and Line 30F
cells, co-cultures were prepared as previously describedJournal of Molecular Signaling 2008, 3:10 http://www.jmolecularsignaling.com/content/3/1/10
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[5] with densities of Line 31E to Line 30F in the ratio of
4:1. After culture for 48 hrs initially in medium supple-
mented with EGF (10 ng/ml), cells were changed for 24
hrs to EDM with 3% foetal calf serum, 5 ug/ml insulin, 1
ug/ml hydrocortisone and 5 ug/ml ovine prolactin. There-
after, supernatants were taken and cells were lysed using
Triton X-100 Lysis Buffer for determination of β-casein in
Western blots or with guanidine thiocyanate buffer, pH
4.0 for isolation of RNA.
For determination of the electrical resistance across the
monolayers of pure cultures of Line 31E cells parallel cul-
tures were grown to confluence on cellulose nitrate filter
inserts (diameter 2.2 cm) in 6-well plates as previously
described [5]. Resistance measurements were obtained
with the Millipore (Bedford, MA., USA) Millicell-ERS
instrument, essentially a milli-volt/ohmmeter that pro-
vides an alternating voltage source to minimise cell dam-
age. Results were expressed as mean values for Ohms ×
cm2 +/- S.E.M. taken on parallel inserts (n = 5).
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